312 related articles for article (PubMed ID: 38072944)
1. Role of N6-methyladenosine methylation in glioma: recent insights and future directions.
Li C; Li B; Wang H; Qu L; Liu H; Weng C; Han J; Li Y
Cell Mol Biol Lett; 2023 Dec; 28(1):103. PubMed ID: 38072944
[TBL] [Abstract][Full Text] [Related]
2. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
Chen F; Xie X; Chao M; Cao H; Wang L
Front Immunol; 2022; 13():917153. PubMed ID: 35711459
[TBL] [Abstract][Full Text] [Related]
3. m6A modification in RNA: biogenesis, functions and roles in gliomas.
Zhang Y; Geng X; Li Q; Xu J; Tan Y; Xiao M; Song J; Liu F; Fang C; Wang H
J Exp Clin Cancer Res; 2020 Sep; 39(1):192. PubMed ID: 32943100
[TBL] [Abstract][Full Text] [Related]
4. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma.
Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L
Front Oncol; 2020; 10():208. PubMed ID: 32211315
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
7. MrGPS: an m6A-related gene pair signature to predict the prognosis and immunological impact of glioma patients.
Zhang N; Yang F; Zhao P; Jin N; Wu H; Liu T; Geng Q; Yang X; Cheng L
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38171932
[TBL] [Abstract][Full Text] [Related]
8. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
9. Insights into the regulatory role of RNA methylation modifications in glioma.
Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
[TBL] [Abstract][Full Text] [Related]
10. The Critical Role of RNA m
Xu Z; Jiang J; Wang S
Cell Mol Neurobiol; 2023 Jul; 43(5):1697-1718. PubMed ID: 36104608
[TBL] [Abstract][Full Text] [Related]
11. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
12. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
13. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents.
Lv J; Xing L; Zhong X; Li K; Liu M; Du K
Biomed Pharmacother; 2023 Jun; 162():114583. PubMed ID: 36989722
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
Sun X; Fu S; Yuan X; Pu X; Wang R; Wang X; Lu H
Cancer Gene Ther; 2023 Sep; 30(9):1209-1214. PubMed ID: 37221404
[TBL] [Abstract][Full Text] [Related]
15. Interaction between m6A methylation and noncoding RNA in glioma.
Tao N; Wen T; Li T; Luan L; Pan H; Wang Y
Cell Death Discov; 2022 Jun; 8(1):283. PubMed ID: 35688823
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
[TBL] [Abstract][Full Text] [Related]
17. The role m
Pan T; Wu F; Li L; Wu S; Zhou F; Zhang P; Sun C; Xia L
Mol Brain; 2021 Jul; 14(1):119. PubMed ID: 34281602
[TBL] [Abstract][Full Text] [Related]
18. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
19. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
[TBL] [Abstract][Full Text] [Related]
20. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
